Enliven Therapeutics (ELVN) Tax Rate (2024)

Enliven Therapeutics (ELVN) reported Tax Rate of 0.94% for Q2 2024.

Enliven Therapeutics (ELVN) Tax Rate (2024) Analysis & Trends

Enliven Therapeutics (ELVN) has 1 years of Tax Rate data on file, last reported at 0.94% in Q2 2024.

For the quarter ending Q2 2024, Tax Rate changed N/A year-over-year to 0.94%; the trailing twelve-month figure through Jun 2025 stood at 0.2% (changed N/A YoY), and the FY2024 full-year result was 0.13%, changed N/A from the prior year.
Tax Rate was little changed at 0.94% in Q2 2024.
In the past five years, Tax Rate ranged from a high of 0.94% in Q2 2024 to a low of 0.94% in Q2 2024.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-0.34%
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	12.29%
4	NuCana	279.75 Bn	279.75 Bn	-	-5.41%
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	17.68%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	12.51%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	33.09%
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Enliven Therapeutics	3.22 Bn	3.22 Bn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2024	-0.94%
Jun 30, 2024	-0.94%
Jun 30, 2024	-0.94%